On ECHEMI
Home > Drugs > Dipyridamole Registered Holders
Dipyridamole structure

Dipyridamole structure

Dipyridamole

Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.Target: Phosphodiesterase (PDE)Dipyridamole concentrations of 1 nmol/ml blood caused 90% inhibition of adenosine metabolism. Dipyridamole at therapeutic concentrations causes significant inhibition of adenosine metabolism in whole blood [1]. Dipyridamole has a dose-dependent inhibitory effect on thromboxane synthesis which was independen

Find 37 Related Holders

QIDONG DONGYUE PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
ALIVUS LIFE SCIENCES LTD
United States United States

API Registration Country

API Active
MATRIX PHARMACORP PRIVATE LTD
United States United States

API Registration Country

API Active
ORCHID PHARMA LTD
United States United States

API Registration Country

API Active
AGC PHARMA CHEMICALS EUROPE SLU
United States United States

API Registration Country

API Active
SOLARA A PHARMA SCIENCES LTD
United States United States

API Registration Country

API Active
SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL
United States United States

API Registration Country

API Active
Yabao Pharmaceutical Group Co., Ltd.
Japan Japan

API Registration Country

API Active
COHANCE LIFESCIENCES LTD
United States United States

API Registration Country

API Active
  • Founded in:

    2005-09-28 00:00:00
  • Country:

    United States United States
八代製薬株式会社
Japan Japan

API Registration Country

API Active
  • Country:

    Japan Japan
Recommended Suppliers of Dipyridamole
View 102 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.